Wai Chun Bio-Technology Limited (HKG:0660)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2600
0.00 (0.00%)
At close: Feb 13, 2026

Wai Chun Bio-Technology Income Statement

Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Dec '21
377.17370.07773.65671.46495.38
Revenue Growth (YoY)
1.92%-52.17%15.22%35.55%-12.72%
Cost of Revenue
341.16335.89723.24611.33457.8
Gross Profit
3634.1850.4160.1237.58
Selling, General & Admin
34.9132.7335.8741.3336.81
Other Operating Expenses
-1.29-1.87-0.320.150.23
Operating Expenses
32.2832.5638.542.1335.95
Operating Income
3.731.6211.9217.991.62
Interest Expense
-13.65-17.91-17.11-13.97-12.82
Interest & Investment Income
0.010.010.040.02-
Other Non Operating Income (Expenses)
2.92-3.13-2.66-
EBT Excluding Unusual Items
-7-19.41-5.166.71-11.2
Gain (Loss) on Sale of Assets
-0.18-0.61-0.03-
Asset Writedown
-1.75-58.15-0.54--
Other Unusual Items
----4.22-
Pretax Income
-8.93-78.17-5.72.52-11.2
Income Tax Expense
1.77-12.464.363.441.45
Earnings From Continuing Operations
-10.7-65.71-10.06-0.93-12.65
Minority Interest in Earnings
-3.9221.5-5.37-13.44-4.38
Net Income
-14.62-44.21-15.43-14.36-17.03
Net Income to Common
-14.62-44.21-15.43-14.36-17.03
Shares Outstanding (Basic)
173171169168167
Shares Outstanding (Diluted)
173171169168167
Shares Change (YoY)
1.15%1.51%0.78%0.14%0.90%
EPS (Basic)
-0.08-0.26-0.09-0.09-0.10
EPS (Diluted)
-0.08-0.26-0.09-0.09-0.10
Free Cash Flow
-24.1212.0520.71-8.01-9.7
Free Cash Flow Per Share
-0.140.070.12-0.05-0.06
Gross Margin
9.55%9.24%6.52%8.95%7.58%
Operating Margin
0.99%0.44%1.54%2.68%0.33%
Profit Margin
-3.88%-11.95%-1.99%-2.14%-3.44%
Free Cash Flow Margin
-6.40%3.26%2.68%-1.19%-1.96%
EBITDA
15.1610.7621.4424.447.67
EBITDA Margin
4.02%2.91%2.77%3.64%1.55%
D&A For EBITDA
11.439.149.526.456.04
EBIT
3.731.6211.9217.991.62
EBIT Margin
0.99%0.44%1.54%2.68%0.33%
Effective Tax Rate
---136.80%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.